Tranzyme

Tranzyme

Biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies.

HQ location
United States
Launch date
Enterprise value
$80—120m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor investor investor investor investor investor investor

€0.0

round

$20.0m

Late VC
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads